About
Brian A. Stearns is a life science executive with over 26 years of experience building and operating companies in San Diego. He began his career at Merck Research Laboratories, became a founding member of Amira Pharmaceuticals (acquired by BMS in 2011), helped found the Versant Ventures-backed incubator Inception Sciences, co-founded Pipeline Therapeutics as President and COO, and served as Chief Scientific Officer at Autobahn Therapeutics. Through his consulting firm Aalchemia he advises on new company creation and holds a PhD in Chemistry from UC Irvine and a BS from Ohio State University.
Invests in
Biotech
Investments
Board seats
Tiger Hill TherapeuticsTilikum
As listed on the firm's website.
Colleagues at Red Tree Venture
Adam Silverman
Red Tree Venture Labs Biologics at Red Tree Venture
Antonio Lepore
Senior Associate at Red Tree Venture
Ariell Ortega
Executive Assistant at Red Tree Venture
Bill Robinson
Scientific Advisory Board - Immunology; Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture
Cassie Lue
VP of Investor Relations at Red Tree Venture
Crystal Mackall
Scientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture
Deborah Nguyen
Red Tree Venture Labs Operating Partner at Red Tree Venture
Frank Longo
Scientific Advisory Board - Neuro; Former Chair, Stanford Dept. of Neurology and Neurological Sciences at Red Tree Venture